| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 1 308-317, Copyright © 1995 by American Association of Immunologists
ARTICLES |
CK Derian, RJ Santulli, PE Rao, HF Solomon and JA Barrett
R. W. Johnson Pharmaceutical Research Institute, Spring House, PA 19477.
An early event associated with neutrophil-dependent tissue damage involves the adhesion of neutrophils to the vascular endothelium and the subsequent release of oxygen-derived free radicals and granule constituents. Elevations in intracellular cAMP are known to inhibit free radical release but not lysosomal enzyme release. The role of cAMP in FMLP-induced neutrophil adhesion was examined in this study by using an in vitro model of neutrophil-endothelial cell adhesion. FMLP stimulated a time- and concentration-dependent increase in human neutrophil adhesion to HUVEC. FMLP-mediated adhesion was inhibited by a diverse group of cAMP modulators: forskolin, isoproterenol, phosphodiesterase IV inhibitors (rolipram and Ro 20-1724), but not phosphodiesterase III inhibitors (milrinone and bemoradan). Endogenous adenosine has previously been shown to mediate FMLP-induced increases in cAMP enhanced in the presence of Ro 20-1724. In this study, adenosine deaminase prevented the inhibitory effects observed with rolipram and Ro 20-1724, implicating endogenous adenosine as a co- modulator of inhibition. FMLP stimulated neutrophil shape change and the surface expression of the beta 2 integrins CD11b/CD18 and CD11a/CD18. Both these responses were inhibited by rolipram but not bemoradan. With the use of 4,4'-diisothiocyanostilbene-2,2'disulfonic acid, we showed that mobilization of the intracellular pool of CD11b/CD18 paralleled adhesion. We conclude that neutrophil-endothelial cell adhesion is attenuated by elevating neutrophil intracellular cAMP and that inhibition of neutrophil CD11b/CD18 surface expression by cAMP accounts for this observed inhibition of adhesion.
This article has been cited by other articles:
|
|
 |
|
  C. D. Chilcoat, Y. Sharief, and S. L. Jones Tonic protein kinase A activity maintains inactive {beta}2 integrins in unstimulated neutrophils by reducing myosin light-chain phosphorylation: role of myosin light-chain kinase and Rho kinase J. Leukoc. Biol., April 1, 2008; 83(4): 964 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lorenowicz, M. Fernandez-Borja, and P. L. Hordijk cAMP Signaling in Leukocyte Transendothelial Migration Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1014 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G D Perkins, N Nathani, D F McAuley, F Gao, and D R Thickett In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury Thorax, January 1, 2007; 62(1): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Maris, A. F. de Vos, M. C. Dessing, C. A. Spek, R. Lutter, H. M. Jansen, J. S. van der Zee, P. Bresser, and T. van der Poll Antiinflammatory Effects of Salmeterol after Inhalation of Lipopolysaccharide by Healthy Volunteers Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ariga, B. Neitzert, S. Nakae, G. Mottin, C. Bertrand, M. P. Pruniaux, S.-L. C. Jin, and M. Conti Nonredundant Function of Phosphodiesterases 4D and 4B in Neutrophil Recruitment to the Site of Inflammation J. Immunol., December 15, 2004; 173(12): 7531 - 7538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Koszalka, B. Ozuyaman, Y. Huo, A. Zernecke, U. Flogel, N. Braun, A. Buchheiser, U. K.M. Decking, M. L. Smith, J. Sevigny, et al. Targeted Disruption of cd73/Ecto-5'-Nucleotidase Alters Thromboregulation and Augments Vascular Inflammatory Response Circ. Res., October 15, 2004; 95(8): 814 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Maris, K. F. van der Sluijs, S. Florquin, A. F. de Vos, J. M. Pater, H. M. Jansen, and T. van der Poll Salmeterol, a {beta}2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1122 - L1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Fleming, M. C. Frame, and M. D. Houslay PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration J. Cell Sci., May 1, 2004; 117(11): 2377 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. VanCompernolle, K. L. Clark, K. A. Rummel, and S. C. Todd Expression and Function of Formyl Peptide Receptors on Human Fibroblast Cells J. Immunol., August 15, 2003; 171(4): 2050 - 2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Coles, A. Bloodsworth, S. R. Clark, M. J. Lewis, A. R. Cross, B. A. Freeman, and V. B. O'Donnell Nitrolinoleate Inhibits Superoxide Generation, Degranulation, and Integrin Expression by Human Neutrophils: Novel Antiinflammatory Properties of Nitric Oxide-Derived Reactive Species in Vascular Cells Circ. Res., September 6, 2002; 91(5): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Jones Protein kinase A regulates {beta}2 integrin avidity in neutrophils J. Leukoc. Biol., June 1, 2002; 71(6): 1042 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Johnson and S. Rennard Alternative Mechanisms for Long-Acting {beta}2-Adrenergic Agonists in COPD Chest, July 1, 2001; 120(1): 258 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Lawrence and K. B. Pryzwansky The Vasodilator-Stimulated Phosphoprotein Is Regulated by Cyclic GMP-Dependent Protein Kinase During Neutrophil Spreading J. Immunol., May 1, 2001; 166(9): 5550 - 5556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. KANEHIRO, T. IKEMURA, M. J. MÄKELÄ, M. LAHN, A. JOETHAM, A. DAKHAMA, and E. W. GELFAND Inhibition of Phosphodiesterase 4 Attenuates Airway Hyperresponsiveness and Airway Inflammation in a Model of Secondary Allergen Challenge Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 173 - 184. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Aoki, M. Kobayashi, J. Ishikawa, Y. Saita, Y. Terai, K. Takayama, K. Miyata, and T. Yamada A Novel Phosphodiesterase Type 4 Inhibitor, YM976 (4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with Little Emetogenic Activity J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 255 - 260. [Abstract] [Full Text]
|
|
|
|
|
|
H. Miettinen, J. Gripentrog, and A. Jesaitis Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin J. Cell Sci., June 8, 2000; 111(14): 1921 - 1928. [Abstract] [PDF]
|
|
|
|
|
|
C. Y. Wang, I. Aronson, S. Takuma, S. Homma, Y. Naka, T. Alshafie, V. Brovkovych, T. Malinski, M. C. Oz, and D. J. Pinsky cAMP Pulse During Preservation Inhibits the Late Development of Cardiac Isograft and Allograft Vasculopathy Circ. Res., May 12, 2000; 86(9): 982 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang and E. J. Brown Immune Complex-induced Integrin Activation and L-plastin Phosphorylation Require Protein Kinase A J. Biol. Chem., August 20, 1999; 274(34): 24349 - 24356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kayano, K. Toda, Y. Naka, K. Okada, M. C. Oz, and D. J. Pinsky SUPERIOR PROTECTION IN ORTHOTOPIC RAT LUNG TRANSPLANTATION WITHCYCLIC ADENOSINE MONOPHOSPHATE AND NITROGLYCERIN-CONTAINING PRESERVATIONSOLUTION J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 135 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Abraham, D. J. Kaneko, and R. Shenkar Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L1 - L8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Miotla, M. M. Teixeira, and P. G. Hellewell Suppression of Acute Lung Injury in Mice by an Inhibitor of Phosphodiesterase Type 4 Am. J. Respir. Cell Mol. Biol., March 1, 1998; 18(3): 411 - 420. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Bauer, M. G. Bouma, I. Herrmann, F. A. J. M. Van Den Wildenberg, G. S. Firestein, I. Marzi, and W. A. Buurman Adenosine kinase inhibitor GP515 attenuates hepatic leukocyte adhesion after hemorrhagic hypotension Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1297 - G1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. TORPHY Phosphodiesterase Isozymes . Molecular Targets for Novel Antiasthma Agents Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 351 - 370. [Full Text]
|
|
|
|
|
|
Y. Naka, D. K. Roy, H. Liao, N. C. Chowdhury, R. E. Michler, M. C. Oz, and D. J. Pinsky cAMP-Mediated Vascular Protection in an Orthotopic Rat Lung Transplant Model: Insights Into the Mechanism of Action of Prostaglandin E1 to Improve Lung Preservation Circ. Res., October 1, 1996; 79(4): 773 - 783. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Sato, S. Sato, T. Yamamoto, S. Ishikawa, M. Onizuka, and Y. Sakakibara Phosphodiesterase type 4 inhibitor reduces the retention of polymorphonuclear leukocytes in the lung Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1376 - L1381. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
